Metropolis Healthcare, the big Indian diagnostic and pathology group, is determined to forestall potential predators despite talk of a $1bn joint bid from hospital chain Apollo and conglomerate Adani Group.
This week we looked at perceived healthcare quality across selected European countries last year based on research conducted by market research company IPSOS.
Listed Malaysian hospital group IHH Healthcare says it will 'vigorously defend' a $6.5bn suit by US fund Emqore relating to the issuance of shares by IHH-owned Indian hospital group Fortis.
Indian private health insurer Star Health has seen just short of four-fifths of its IPO offer subscribed in the past three days of book building. However, local press reports that the listing will still go through thanks to a downsized secondary offer.
The Indian government's slowness to approve booster shots is putting lives at risk - particularly those of front line medical staff whose immunity is waning. HBI speaks to a disappointed operator source in the country to find out more.
UAE and Indian hospital business Aster DM has tasked bankers to look at a demerger between the two geographies. Chairman Azad Moopen has said this makes more room for capex on the high-growth Indian business.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
